WRM
BHVN icon

Weybosset Research & Management’s Biohaven BHVN Stock Holding History

Weybosset Research & Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$194K Hold
22,990
– – 0.06% 33
2025
Q4 		$260K Buy
22,990
+50
+0.2% +$619 0.08% 34
2025
Q3 		$344K Buy
22,940
+3,660
+19% +$53.3K 0.11% 30
2025
Q2 		$272K Buy
19,280
+2,400
+14% +$42.8K 0.09% 32
2025
Q1 		$406K Buy
16,880
+3,235
+24% +$114K 0.14% 28
2024
Q4 		$510K Buy
13,645
+2,635
+24% +$123K 0.17% 29
2024
Q3 		$550K Hold
11,010
– – 0.19% 29
2024
Q2 		$382K Sell
11,010
-2,630
-19% -$104K 0.14% 30
2024
Q1 		$5.08K Hold
13,640
– – 1.77% 20
2023
Q4 		$584K Buy
13,640
+1,500
+12% +$46.6K 0.21% 28
2023
Q3 		$316K Buy
12,140
+2,000
+20% +$41.6K 0.13% 31
2023
Q2 		$243K Buy
+10,140
New +$175K 0.09% 33

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Weybosset Research & Management's BHVN Position: Q1 2026 in Review

Weybosset Research & Management held its Biohaven (BHVN) position steady in Q1 2026 at 22,990 shares worth $194K. The position accounts for 0.06% of the portfolio, ranked #33.

Weybosset Research & Management first reported a position in BHVN in Q2 2023 and has held it in 12 quarters since. The position peaked at $584K in Q4 2023. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Weybosset Research & Management held 22,990 shares of Biohaven worth $194K as of Q1 2026.
  • Weybosset Research & Management left its Biohaven share count unchanged in Q1 2026.
  • Biohaven made up 0.06% of Weybosset Research & Management's portfolio in Q1 2026, its #33 holding.
  • Weybosset Research & Management first reported a position in Biohaven in Q2 2023 and has held it in 12 quarters since.
  • Weybosset Research & Management's Biohaven position peaked at $584K in Q4 2023.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Weybosset Research & Management's 13F filing for Q1 2026, filed 16 Apr 2026.